Blume-Jensen Peter Insider Trades

Insider Trading History

Track insider trading activity for Blume-Jensen Peter. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.78M 2,245,317 shares
Last Trade
May 21, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.6k 13,729 shares
$1.79
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.81M 2,259,046 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 180,095 shares
$1.65
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $823k 386,343 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 72,706 shares
$1.65
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $668k 313,637 shares
Last Trade
May 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$941 490 shares
$1.92
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.43M 2,078,951 shares
Last Trade
May 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.41k 1,253 shares
$1.92
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $395k 185,495 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$280k 185,495 shares
$1.51
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $889k 417,210 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 417,210 shares
$1.51
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.43M 2,080,204 shares
Last Trade
Feb 21, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.8k 14,265 shares
$1.53
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.46M 2,094,469 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.12k 1,302 shares
$1.63
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $669k 314,127 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$944 579 shares
$1.63
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.46M 2,095,771 shares
Last Trade
Jan 14, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.3k 49,000 shares
$1.68
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.36M 2,046,771 shares
Last Trade
Nov 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.8k 19,904 shares
$2.30
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $670k 314,706 shares
Last Trade
Nov 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.1k 490 shares
$2.24
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.4M 2,066,675 shares
Last Trade
Nov 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$134k 59,765 shares
$2.24
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.53M 2,126,440 shares
Last Trade
Aug 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.3k 19,905 shares
$1.32
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.57M 2,146,345 shares
Last Trade
Aug 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$83.8k 60,256 shares
$1.39
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.7M 2,206,111 shares
Last Trade
May 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.9k 19,904 shares
$1.15
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.74M 2,226,015 shares
Last Trade
May 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$68.7k 60,257 shares
$1.14
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $832k 390,390 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.82M 530,930 shares
$5.31
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $4.87M 2,285,781 shares
Last Trade
Feb 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$110k 19,904 shares
$5.54
$2.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up